In:
RMD Open, BMJ, Vol. 9, No. 3 ( 2023-09), p. e003081-
Abstract:
Some myopathies can lead to dropped head or bent spine syndrome (DH/BS). The significance of this symptom has not been studied in inflammatory myopathies (IM). Objectives To assess the significance of DH/BS in patients with IM. Methods Practitioners from five IM networks were invited to report patients with IM suffering from DH/BS (without other known cause than IM). IM patients without DH/BS, randomly selected in each participating centre, were included as controls at a ratio of 2 to 1. Results 49 DH/BS-IM patients (DH: 57.1%, BS: 42.9%) were compared with 98 control-IM patients. DH/BS-IM patients were older (65 years vs 53 years, p 〈 0.0001) and the diagnosis of IM was delayed (6 months vs 3 months, p=0.009). Weakness prevailing in the upper limbs (42.9% vs 15.3%), dysphagia (57.1% vs 25.5%), muscle atrophy (65.3% vs 34.7%), weight loss (61.2% vs 23.5%) and loss of the ability to walk (24.5% vs 5.1%) were hallmarks of DH/BS-IM (p≤0.0005), for which the patients more frequently received intravenous immunoglobulins (65.3% vs 34.7%, p=0.0004). Moreover, DH/BS-IM patients frequently featured signs and/or complications of systemic sclerosis (SSc), fulfilling the American College of Rheumatology/European Alliance of Associations for Rheumatology criteria for this disease in 40.8% of the cases (vs 5.1%, p 〈 0.0001). Distribution of the myopathy, its severity and its association with SSc were independently associated with DH/BS (p 〈 0.05). Mortality was higher in the DH/BS-IM patients and loss of walking ability was independently associated with survival (p 〈 0.05). Conclusion In IM patients, DH/BS is a marker of severity and is associated with SSc (scleromyositis).
Type of Medium:
Online Resource
ISSN:
2056-5933
DOI:
10.1136/rmdopen-2023-003081
Language:
English
Publisher:
BMJ
Publication Date:
2023
detail.hit.zdb_id:
2812592-7
